Fig. 2 | Signal Transduction and Targeted Therapy

Fig. 2

From: A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5

Fig. 2

Neutralizing activity of CR9 against SARS-CoV-2. a Neutralizing abilities of antibody CR9 against the five Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, BA.5 and wild type(WH-09) in vitro. Irrelevant human immunoglobulin G (IgG) was used as a control. b Neutralizing abilities of antibody CR9 against the two pseudoviruses Omicron sub-variants BA.2.86 and JN.1. in vitro. Pseudoviruses HIV was used as a control

Back to article page